Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 30, 2004
Money is being directed to the Red Cross' International Response Fund.
-
Dec 20, 2004
Expansion of management structure is designed to position the Company for continued growth and success.
-
Dec 16, 2004
The transaction is expected to close early next year.
-
Dec 2, 2004
Motions for summary judgment were granted in part and denied in part.
-
Nov 24, 2004
A live webcast and replay of the December 1 conference session will be available.
-
Nov 23, 2004
An existing licensing agreement with Angiotech Pharmaceuticals, Inc. allows Company to obtain an exclusive license for the use of paclitaxel and other agents in the coronary vascular field.
-
Nov 22, 2004
French government adds new patient categories to reimbursement approval criteria.
-
Nov 18, 2004
Company plans to use the proceeds to repay commercial paper borrowings and for other general corporate purposes.
-
Nov 16, 2004
Equity investment in a privately held company developing a balloon-expandable, bioresorbable drug-eluting stent.
-
Nov 15, 2004
The two series of senior notes will have varied maturities and a combined aggregate principal amount of $500 million.